Verbatim response from ChatGPT
Short answer: online clinics generally find it easier to prescribe Ozempic (semaglutide formulated/marketed for diabetes) off‑label for weight loss than Wegovy (semaglutide specifically FDA‑approved for chronic weight management). But clinics that specialize in obesity/weight‑loss programs are likelier to seek Wegovy when you meet the BMI/medical criteria and pursue prior authorization.
Why:
- Regulatory/labeling: Wegovy is FDA‑approved for weight loss at a 2.4 mg weekly dose; Ozempic is approved for type 2 diabetes at lower doses (up to 2.0 mg). Because Wegovy is the on‑label weight‑loss product, providers who want to follow label and documentation rules will prefer Wegovy.
- Off‑label prescribing: Many general telemedicine or primary‑care telehealth services will prescribe Ozempic off‑label for weight loss more readily (especially if Wegovy is unavailable or insurance won’t cover it). Some providers avoid off‑label use for liability or clinical reasons, so practice varies.
- Access and cost: Wegovy has had supply/coverage/pricing hurdles; some clinicians and patients choose Ozempic (or other GLP‑1s) because it’s more available or cheaper, even if the dose/formulation differs.
Examples of services (what they tend to do)
- Calibrate — specialty metabolic/weight‑loss program. More likely to pursue on‑label Wegovy (or other approved weight‑loss agents) and to handle prior authorization and long‑term metabolic care. Good if you want an obesity‑focused program and follow‑up.
- Hims & Hers — consumer telehealth that has offered GLP‑1 weight‑loss programs; convenient and priced for direct‑to‑consumer access (may prescribe semaglutide depending on assessment).
- PlushCare — general telemedicine/primary‑care platform; clinicians will often consider semaglutide and may prescribe Ozempic off‑label or Wegovy if appropriate. Fast access but varies by clinician.
- SteadyMD / Forward / Carbon Health — membership or primary‑care telehealth services where a named clinician manages chronic care and may prescribe GLP‑1 therapy based on your history; practice patterns differ (some favor on‑label Wegovy if criteria met, others use Ozempic off‑label).
What to do next
- Ask any clinic directly whether they prescribe Wegovy vs Ozempic, whether they require BMI/medical documentation, and whether they help with prior authorization/insurance.
- Prefer clinics that do baseline labs and ongoing follow‑up (electrolytes, kidney function, monitoring for side effects).
- Consider cost/coverage: insurance often covers Wegovy only with prior authorization and specific BMI/comorbidity criteria; Ozempic for weight loss is frequently out‑of‑pocket if prescribed off‑label.
If you want, tell me your location, BMI/medical history, and whether you care more about insurance coverage vs speed/cost, and I can suggest which type of telemedicine provider to contact or name a specific service near you.